563 related articles for article (PubMed ID: 18618617)
21. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF.
Price A; Manson D; Cutz E; Dell S
Pediatr Pulmonol; 2006 Apr; 41(4):367-70. PubMed ID: 16475176
[No Abstract] [Full Text] [Related]
22. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosis.
Shende RP; Sampat BK; Prabhudesai P; Kulkarni S
J Assoc Physicians India; 2013 Mar; 61(3):209-11. PubMed ID: 24475687
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary alveolar proteinosis.
Khan A; Agarwal R
Respir Care; 2011 Jul; 56(7):1016-28. PubMed ID: 21496372
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary alveolar proteinosis.
Wang T; Lazar CA; Fishbein MC; Lynch JP
Semin Respir Crit Care Med; 2012 Oct; 33(5):498-508. PubMed ID: 23001804
[TBL] [Abstract][Full Text] [Related]
26. GM-CSF pathway correction in pulmonary alveolar proteinosis.
Antoniu SA
Expert Opin Biol Ther; 2010 Sep; 10(9):1357-65. PubMed ID: 20695835
[TBL] [Abstract][Full Text] [Related]
27. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
Venkateshiah SB; Yan TD; Bonfield TL; Thomassen MJ; Meziane M; Czich C; Kavuru MS
Chest; 2006 Jul; 130(1):227-37. PubMed ID: 16840407
[TBL] [Abstract][Full Text] [Related]
28. Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report.
Vojcek E; Krikovszky D; Lódi C; Kovács L; Schnur J; Szabó AJ
Ital J Pediatr; 2024 Jun; 50(1):111. PubMed ID: 38831374
[TBL] [Abstract][Full Text] [Related]
29. [Progress in the treatment options of pulmonary alveolar proteinosis].
Zhao Y; Xu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):444-7. PubMed ID: 25200046
[No Abstract] [Full Text] [Related]
30. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.
Seymour JF; Presneill JJ; Schoch OD; Downie GH; Moore PE; Doyle IR; Vincent JM; Nakata K; Kitamura T; Langton D; Pain MC; Dunn AR
Am J Respir Crit Care Med; 2001 Feb; 163(2):524-31. PubMed ID: 11179134
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
[TBL] [Abstract][Full Text] [Related]
32. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
[TBL] [Abstract][Full Text] [Related]
33. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.
Latzin P; Tredano M; Wüst Y; de Blic J; Nicolai T; Bewig B; Stanzel F; Köhler D; Bahuau M; Griese M
Thorax; 2005 Jan; 60(1):39-44. PubMed ID: 15618581
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary Alveolar Proteinosis Syndrome.
Suzuki T; Trapnell BC
Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
[TBL] [Abstract][Full Text] [Related]
35. [Multidisciplinary assessment of effects, safety and procedure of whole lung lavage for 8 patients with autoimmune pulmonary alveolar proteinosis].
Sugimoto C; Arai T; Nishiyama A; Inoue Y; Kagawa T; Akira M; Matsumuro A; Hirose M; Kitaichi M; Hayashi S; Inoue Y
Nihon Kokyuki Gakkai Zasshi; 2011 Aug; 49(8):569-76. PubMed ID: 21894771
[TBL] [Abstract][Full Text] [Related]
36. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
Campo I; Carey BC; Paracchini E; Kadija Z; De Silvestri A; Rodi G; De Amici M; Torre C; Zorzetto M; Griese M; Meloni F; Corsico AG; Trapnell BC; Mariani F
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37973175
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage.
Abdul Rahman JA; Moodley YP; Phillips MJ
Respirology; 2004 Aug; 9(3):419-22. PubMed ID: 15497254
[TBL] [Abstract][Full Text] [Related]
38. Therapy options in pulmonary alveolar proteinosis.
Luisetti M; Kadija Z; Mariani F; Rodi G; Campo I; Trapnell BC
Ther Adv Respir Dis; 2010 Aug; 4(4):239-48. PubMed ID: 20647242
[TBL] [Abstract][Full Text] [Related]
39. Whole lung lavage: the salvage therapy for pulmonary alveolar proteinosis.
Indira KS; Rajesh V; Darsana V; Ranjit U; John J; Vengadakrishnaraj SP; Dharmadhikari SA
Indian J Chest Dis Allied Sci; 2007; 49(1):41-4. PubMed ID: 17256566
[TBL] [Abstract][Full Text] [Related]
40. Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor.
Satoh H; Tazawa R; Sakakibara T; Ohkouchi S; Ebina M; Miki M; Nakata K; Nukiwa T
Intern Med; 2012; 51(13):1737-42. PubMed ID: 22790136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
